1. Home
  2. CLLS vs SPCE Comparison

CLLS vs SPCE Comparison

Compare CLLS & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • SPCE
  • Stock Information
  • Founded
  • CLLS 1999
  • SPCE 2017
  • Country
  • CLLS France
  • SPCE United States
  • Employees
  • CLLS N/A
  • SPCE N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • SPCE Transportation Services
  • Sector
  • CLLS Health Care
  • SPCE Consumer Discretionary
  • Exchange
  • CLLS Nasdaq
  • SPCE Nasdaq
  • Market Cap
  • CLLS 143.4M
  • SPCE 148.0M
  • IPO Year
  • CLLS 2007
  • SPCE N/A
  • Fundamental
  • Price
  • CLLS $1.59
  • SPCE $3.12
  • Analyst Decision
  • CLLS Buy
  • SPCE Hold
  • Analyst Count
  • CLLS 1
  • SPCE 5
  • Target Price
  • CLLS $4.00
  • SPCE $11.05
  • AVG Volume (30 Days)
  • CLLS 48.2K
  • SPCE 2.5M
  • Earning Date
  • CLLS 08-05-2025
  • SPCE 08-06-2025
  • Dividend Yield
  • CLLS N/A
  • SPCE N/A
  • EPS Growth
  • CLLS N/A
  • SPCE N/A
  • EPS
  • CLLS N/A
  • SPCE N/A
  • Revenue
  • CLLS $54,747,000.00
  • SPCE $5,512,000.00
  • Revenue This Year
  • CLLS $48.52
  • SPCE N/A
  • Revenue Next Year
  • CLLS $5.17
  • SPCE $4,110.27
  • P/E Ratio
  • CLLS N/A
  • SPCE N/A
  • Revenue Growth
  • CLLS 351.26
  • SPCE N/A
  • 52 Week Low
  • CLLS $1.10
  • SPCE $2.18
  • 52 Week High
  • CLLS $2.43
  • SPCE $8.32
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 56.98
  • SPCE 54.42
  • Support Level
  • CLLS $1.56
  • SPCE $2.72
  • Resistance Level
  • CLLS $1.49
  • SPCE $2.91
  • Average True Range (ATR)
  • CLLS 0.09
  • SPCE 0.13
  • MACD
  • CLLS 0.01
  • SPCE 0.03
  • Stochastic Oscillator
  • CLLS 80.00
  • SPCE 94.57

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About SPCE Virgin Galactic Holdings Inc.

Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.

Share on Social Networks: